German Patient Advocacy
🚨 Patient Access is Transforming the German Cannabis Market 🚨
The German Medical Cannabis Act (CanG) went into effect on April 1, 2024, legalizing cannabis possession and home cultivation. While that is great news for patient advocates, the most compelling part of CanG is the removal of cannabis from the narcotics list. This change means Germany’s fast growing number of medical cannabis patients have easier access to cannabis treatments.
The number of medical patients in Germany is rising quickly as the legal market expands, with a projected 14.9% CAGR through 2030.
Unlike the U.S.—where cannabis is highly politicized and recreational markets dominate — medical cannabis is central to Germany’s legal landscape.
Here are 3 things global cannabis execs need to know about how Europe’s largest cannabis market is shaping up:
Market Expansion: With Germany’s domestic cultivation caps lifted, more companies are entering the medical cultivation market. Remember: the cultivation must be EU GMP certified. Almost zero cultivations in the US operate at this level. This means more competition, more strains, and higher quality products. 🌱
Insurance-Backed Sales: The highly celebrated G-BA decision that was announced July 25, 2024 means doctors and other medical service providers are no longer required to seek pre-approval from insurance companies before prescribing cannabis as a first-line treatment for over 16 common ailments and five additional chronic conditions. This means insurance coverage for cannabis prescriptions is more accessible than ever. This development will create a bigger, more stable, and accessible medical market. 💰
Custom Products on the Rise: Germany’s medical cannabis products are highly customizable when offered through compound pharmacies. This often overlooked loophole provides businesses the opportunity to help doctors and pharmacists tailor treatments to individual patients’ needs. 🏥
So what’s the next move in Germany’s medical market?
Companies looking to jump into the German market should have business plans that include efficiently leveraging the medical insurance program, allowing patients greater access to their products without having to use their disposable income.
Have you ever dealt with Germany’s medical cannabis system? Let’s talk in the comments!
♻️ Repost if you know someone who needs this info.
